Retail & Wholesale » Retail | UDG Healthcare PLC

UDG Healthcare PLC | Income Statement

Fiscal year is October-September. All values GBP Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,709
626
682
738
963
978,476.20
Cost of Goods Sold (COGS) incl. D&A
1,449
419
498
528
708
717,879.70
Gross Income
261
207
184
209
255
260,596.50
SG&A Expense
200
163
124
139
170
175,411.90
EBIT
-
-
-
-
84
83,009.20
Unusual Expense
26
16
8
2
15
43,054.30
Non Operating Income/Expense
2
34
18
2
11
28,594.30
Interest Expense
10
13
10
9
9
7,146
Pretax Income
23
82
40
58
73
5,526.30
Income Tax
5
9
10
11
17
3,369.50
Equity in Affiliates
-
6
6
1
1
712.70
Consolidated Net Income
23
80
29
48
57
2,869.50
Net Income
23
80
29
48
57
2,823.40
Net Income After Extraordinaries
23
69
18
55
57
2,823.40
Net Income Available to Common
23
90
41
48
57
2,823.40
EPS (Basic)
0.10
0.37
0.17
0.61
0.23
0.01
Basic Shares Outstanding
240
242
244
246
248
248,517.70
EPS (Diluted)
0.10
0.37
0.17
0.61
0.23
0.01
Diluted Shares Outstanding
241
243
245
247
249
250,464.80
EBITDA
89
67
84
97
121
128,774.60
Other Operating Expense
-
-
1
-
-
2,175.40
Non-Operating Interest Income
-
259.60
318.10
1
1
1,311.60
Minority Interest Expense
-
-
-
-
-
46.10

About UDG Healthcare

View Profile
Address
20 Riverwalk
Dublin Dublin 24
Ireland
Employees -
Website http://www.udghealthcare.com
Updated 07/08/2019
UDG Healthcare Plc engages in the supply and distribution of pharmaceutical and medical products. It operates through the following segments: Ashfield, Sharp, and Aquilant. The Ashfield segment provides commercialization services for the pharmaceutical and healthcare industry.